BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35838970)

  • 1. Evaluation Protocol for SARS-CoV-2 Serological Assays.
    Gededzha MP; Jugwanth S; Mampeule N; Zwane N; David A; Scott L; Stevens W; Mayne ES
    Methods Mol Biol; 2022; 2511():307-319. PubMed ID: 35838970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Lateral Flow Immunoassay COVIDTECH
    Exinger J; Hartard C; Lafferrière F; Fenninger C; Charbonnière LJ; Jeulin H
    Jpn J Infect Dis; 2022 Jul; 75(4):334-340. PubMed ID: 34980703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
    Peghin M; Bontempo G; De Martino M; Palese A; Gerussi V; Graziano E; Fabris M; D'Aurizio F; Sbrana F; Ripoli A; Curcio F; Isola M; Tascini C
    BMC Infect Dis; 2022 Oct; 22(1):810. PubMed ID: 36316641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
    Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
    J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
    J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays.
    Mafi S; Rogez S; Darreye J; Alain S; Hantz S
    Diagn Microbiol Infect Dis; 2023 Apr; 105(4):115900. PubMed ID: 36716586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen.
    Johnson L; Bartlett ML; Ramirez F; Heger CD; Smith DR
    J Immunol Methods; 2024 Jan; 524():113586. PubMed ID: 38040191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to interpret and use COVID-19 serology and immunology tests.
    Ong DSY; Fragkou PC; Schweitzer VA; Chemaly RF; Moschopoulos CD; Skevaki C;
    Clin Microbiol Infect; 2021 Jul; 27(7):981-986. PubMed ID: 33975005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies.
    Deshpande PS; Abraham IE; Pitamberwale A; Dhote RH
    Viral Immunol; 2022 Mar; 35(2):82-111. PubMed ID: 35007431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
    Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of 14 SARS-CoV-2 serological assays and their diagnostic potential in RT-PCR negative COVID-19 infections.
    Van Honacker E; Coorevits L; Boelens J; Verhasselt B; Van Braeckel E; Bauters F; De Bus L; Schelstraete P; Willems J; Vandendriessche S; Padalko E
    Acta Clin Belg; 2022 Apr; 77(2):315-320. PubMed ID: 33350362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan.
    Lin YC; Lee YL; Cheng CY; Tseng WP; Wu JL; Lin CH; Chung MY; Kang CM; Lee YF; Chen CP; Huang CH; Liu CE; Cheng SH; Chen SC; Chen SY; Hsueh PR
    J Microbiol Immunol Infect; 2021 Oct; 54(5):816-829. PubMed ID: 33676864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
    Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
    Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
    Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F
    Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.